Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Every Patient In This Bowel Cancer Trial Has Been Cancer Free For Nearly Three Years

In one of the most striking results from any cancer clinical trial in recent years, every single patient in a bowel cancer study has remained cancer-free for nearly three years after receiving a short course of immunotherapy before surgery, with zero relapses recorded in the entire cohort as of the latest follow-up data. The NEOPRISM-CRC trial, led by researchers at University College London and University College London Hospitals, gave patients with a specific form of stage two or three bowel cancer nine weeks of pre-operative treatment with the immunotherapy drug pembrolizumab, replacing the conventional approach of post-operative chemotherapy. Initial results showed that 59 percent of patients had no detectable cancer after the immunotherapy and surgery combined, and the new follow-up data at 33 months shows that not only have those patients remained clear, but even the patients who still had small amounts of cancer remaining after treatment saw none of it grow or spread. Under the standard treatment pathway, roughly 25 percent of similar patients would be expected to relapse within three years.

The results were presented at the American Association for Cancer Research Annual Meeting in April 2026 and have generated significant excitement among oncologists. The specific bowel cancer treated in the trial, known as mismatch repair-deficient cancer, affects roughly 15 percent of all bowel cancer patients and is characterized by genetic errors that make it particularly responsive to immunotherapy. Researchers noted that the results suggest a nine-week drug course could replace months of chemotherapy and provide more durable protection against recurrence, a potential shift in how this form of the disease is treated from the ground up. Scientists called the zero-relapse figure at nearly three years extraordinary, and said larger trials are now needed to confirm and extend the findings across wider patient populations.

Source: https://scitechdaily.com/breakthrough-bowel-cancer-trial-leaves-patients-cancer-free-for-nearly-3-years/

PrevPreviousColorado Just Banned Pet Store Dog And Cat Sales
NextA 12-Year-Old Fighting Brain Cancer Raised $22 At A Lemonade Stand For Research And Then Something Incredible HappenedNext

Recent Articles

Happy News

Communities Across America Are Banning AI Data Centers And The Number Just Jumped From 8 To 78

May 10, 2026

According to the U.S. Data Center Moratorium Tracker, communities across the country have been pushing back against the rapid expansion of AI data centers with growing success, with the number of active bans and moratoriums jumping from just 8 in May 2025 to 78 today, including 50 active restrictions and

Read More
Happy News

An Alaska Animal Shelter Lets You Borrow A Dog For 48 Hours And It Is Leading To More Adoptions

May 10, 2026

The Anchorage Animal Care and Control shelter in Alaska launched a program in spring 2025 called Tails on Trails that has since become one of the most talked-about shelter initiatives in the country, pairing volunteers with a shelter dog for 48 hours and sending them out to explore the trails

Read More
Happy News

Scientists Gave Monkeys A Reward-Free Video Game And They Played Nearly 100 Rounds Anyway

May 10, 2026

Researchers at Kyoto University’s Institute for the Evolutionary Origins of Human Behavior set out to test whether curiosity in Japanese macaques follows the same pattern observed in humans, and what they found should resonate with anyone who has ever gone down a late-night internet rabbit hole for no practical reason

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.